Stopping nucleos(t)ide analogue treatment in Caucasian hepatitis B patients after HBeAg seroconversion is associated with high relapse rates and fatal outcomes

Stijn Hees; S Bourgeois; H van Vlierberghe; T Serste; S Francque; P Michielsen; D Sprengers; H Reynaert; J Henrion; SN Dastis; J Delwaide; L Lasser; J Decaestecker; H Orlent; F Janssens; G Robaeys; I Colle; P Starkel; C Moreno; F Nevens; Thomas Vanwolleghem

doi:10.1111/apt.14560

Stopping nucleos(t)ide analogue treatment in Caucasian hepatitis B patients after HBeAg seroconversion is associated with high relapse rates and fatal outcomes

Stijn Hees, S Bourgeois, H van Vlierberghe, T Serste, S Francque, P Michielsen, D Sprengers, H Reynaert, J Henrion, SN Dastis, J Delwaide, L Lasser, J Decaestecker, H Orlent, F Janssens, G Robaeys, I Colle, P Starkel, C Moreno, F NevensThomas Vanwolleghem

Gastroenterology & Hepatology

Research output: Contribution to journal › Article › Academic › peer-review

49 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	1170-1180
Number of pages	11
Journal	Alimentary Pharmacology & Therapeutics
Volume	47
Issue number	8
DOIs	https://doi.org/10.1111/apt.14560
Publication status	Published - 2018

Research programs

EMC MM-04-20-02-A

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/apt.14560

http://hdl.handle.net/1765/111096

Cite this

Hees, S., Bourgeois, S., van Vlierberghe, H., Serste, T., Francque, S., Michielsen, P., Sprengers, D., Reynaert, H., Henrion, J., Dastis, SN., Delwaide, J., Lasser, L., Decaestecker, J., Orlent, H., Janssens, F., Robaeys, G., Colle, I., Starkel, P., Moreno, C., ... Vanwolleghem, T. (2018). Stopping nucleos(t)ide analogue treatment in Caucasian hepatitis B patients after HBeAg seroconversion is associated with high relapse rates and fatal outcomes. Alimentary Pharmacology & Therapeutics, 47(8), 1170-1180. https://doi.org/10.1111/apt.14560

@article{db61aeca57e641d9b1d3cc75602b5ff1,

title = "Stopping nucleos(t)ide analogue treatment in Caucasian hepatitis B patients after HBeAg seroconversion is associated with high relapse rates and fatal outcomes",

author = "Stijn Hees and S Bourgeois and {van Vlierberghe}, H and T Serste and S Francque and P Michielsen and D Sprengers and H Reynaert and J Henrion and SN Dastis and J Delwaide and L Lasser and J Decaestecker and H Orlent and F Janssens and G Robaeys and I Colle and P Starkel and C Moreno and F Nevens and Thomas Vanwolleghem",

year = "2018",

doi = "10.1111/apt.14560",

language = "Undefined/Unknown",

volume = "47",

pages = "1170--1180",

journal = "Alimentary Pharmacology & Therapeutics",

issn = "0269-2813",

publisher = "Wiley-Blackwell Publishing Ltd",

number = "8",

}

Hees, S, Bourgeois, S, van Vlierberghe, H, Serste, T, Francque, S, Michielsen, P, Sprengers, D, Reynaert, H, Henrion, J, Dastis, SN, Delwaide, J, Lasser, L, Decaestecker, J, Orlent, H, Janssens, F, Robaeys, G, Colle, I, Starkel, P, Moreno, C, Nevens, F & Vanwolleghem, T 2018, 'Stopping nucleos(t)ide analogue treatment in Caucasian hepatitis B patients after HBeAg seroconversion is associated with high relapse rates and fatal outcomes', Alimentary Pharmacology & Therapeutics, vol. 47, no. 8, pp. 1170-1180. https://doi.org/10.1111/apt.14560

Stopping nucleos(t)ide analogue treatment in Caucasian hepatitis B patients after HBeAg seroconversion is associated with high relapse rates and fatal outcomes. / Hees, Stijn; Bourgeois, S; van Vlierberghe, H et al.
In: Alimentary Pharmacology & Therapeutics, Vol. 47, No. 8, 2018, p. 1170-1180.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Stopping nucleos(t)ide analogue treatment in Caucasian hepatitis B patients after HBeAg seroconversion is associated with high relapse rates and fatal outcomes

AU - Hees, Stijn

AU - Bourgeois, S

AU - van Vlierberghe, H

AU - Serste, T

AU - Francque, S

AU - Michielsen, P

AU - Sprengers, D

AU - Reynaert, H

AU - Henrion, J

AU - Dastis, SN

AU - Delwaide, J

AU - Lasser, L

AU - Decaestecker, J

AU - Orlent, H

AU - Janssens, F

AU - Robaeys, G

AU - Colle, I

AU - Starkel, P

AU - Moreno, C

AU - Nevens, F

AU - Vanwolleghem, Thomas

PY - 2018

Y1 - 2018

U2 - 10.1111/apt.14560

DO - 10.1111/apt.14560

M3 - Article

C2 - 29498078

SN - 0269-2813

VL - 47

SP - 1170

EP - 1180

JO - Alimentary Pharmacology & Therapeutics

JF - Alimentary Pharmacology & Therapeutics

IS - 8

ER -